ERBB2 and breast cancer: Nevertheless, we still found that the accuracy of self-reporting tumor characteristics such as in situ type as well as other less common breast cancer subtypes such as lobular only, hormone receptor negative, and HER2 positive breast cancer was somewhat problematic.